Omitting axillary dissection in breast cancer with sentinel-node metastases
…, E Wieslander, H Dahl Nissen, S Alkner… - … England Journal of …, 2024 - Mass Medical Soc
Background Trials evaluating the omission of completion axillary-lymph-node dissection in
patients with clinically node-negative breast cancer and sentinel-lymph-node metastases …
patients with clinically node-negative breast cancer and sentinel-lymph-node metastases …
Surface guided radiotherapy (SGRT) improves breast cancer patient setup accuracy
…, S Nørring Bekke, S Alkner… - Journal of applied …, 2019 - Wiley Online Library
Purpose The purpose of the study was to investigate if surface guided radiotherapy (SGRT)
can decrease setup deviations for tangential and locoregional breast cancer patients …
can decrease setup deviations for tangential and locoregional breast cancer patients …
[HTML][HTML] Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
Background Adjuvant endocrine treatment improves survival after estrogen receptor (ER)
positive breast cancer. Recurrences occur, and most patients with metastatic breast cancer …
positive breast cancer. Recurrences occur, and most patients with metastatic breast cancer …
[HTML][HTML] Clinical validation of a commercially available deep learning software for synthetic CT generation for brain
M Lerner, J Medin, C Jamtheim Gustafsson, S Alkner… - Radiation …, 2021 - Springer
Background Most studies on synthetic computed tomography (sCT) generation for brain rely
on in-house developed methods. They often focus on performance rather than clinical …
on in-house developed methods. They often focus on performance rather than clinical …
[HTML][HTML] Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis
V Salvestrini, K Kim, S Caini, S Alkner, M Ekholm… - Radiotherapy and …, 2023 - Elsevier
Background and Purpose In recent years, the treatment landscape for breast cancer has
undergone significant advancements, with the introduction of several new anticancer agents. …
undergone significant advancements, with the introduction of several new anticancer agents. …
Dosimetric effects of intrafractional isocenter variation during deep inspiration breath‐hold for breast cancer patients using surface‐guided radiotherapy
…, A Edvardsson, L Berg, S Alkner… - Journal of applied …, 2018 - Wiley Online Library
The aim of this study was to investigate potential dose reductions to the heart, left anterior
descending coronary artery ( LAD ), and ipsilateral lung for left‐sided breast cancer using …
descending coronary artery ( LAD ), and ipsilateral lung for left‐sided breast cancer using …
Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon …
A Edvardsson, M Kügele, S Alkner, M Enmark… - Acta …, 2019 - Taylor & Francis
Background: Late effects induced by radiotherapy (RT) are of great concern for mediastinal
Hodgkin’s lymphoma (HL) patients and it is therefore important to reduce normal tissue dose. …
Hodgkin’s lymphoma (HL) patients and it is therefore important to reduce normal tissue dose. …
[HTML][HTML] Prospective clinical feasibility study for MRI-only brain radiotherapy
…, J Medin, C Jamtheim Gustafsson, S Alkner… - Frontiers in …, 2022 - frontiersin.org
Objectives MRI-only radiotherapy (RT) provides a workflow to decrease the geometric
uncertainty introduced by the image registration process between MRI and CT data and to …
uncertainty introduced by the image registration process between MRI and CT data and to …
[HTML][HTML] Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in …
…, L Rydén, M Fernö, LMF Leeb-Lundberg, S Alkner - PloS one, 2020 - journals.plos.org
Background G protein-coupled estrogen receptor (GPER), or G protein-coupled receptor 30
(GPR30), is reported to mediate non-genomic estrogen signaling. GPR30 associates with …
(GPR30), is reported to mediate non-genomic estrogen signaling. GPR30 associates with …
[HTML][HTML] Prediction of outcome after diagnosis of metachronous contralateral breast cancer
S Alkner, PO Bendahl, M Fernö, J Manjer, L Rydén - Bmc Cancer, 2011 - Springer
Background Although 2-20% of breast cancer patients develop a contralateral breast
cancer (CBC), prognosis after CBC is still debated. Using a unique patient cohort, we have …
cancer (CBC), prognosis after CBC is still debated. Using a unique patient cohort, we have …
